Colorectal Cancer
Showing NaN - NaN of 80
Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +19 more
- A2B694
- xT CDx with HLA-LOH Assay
-
Duarte, California
- +9 more
Sep 22, 2023
Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +15 more
- A2B530
- xT-Onco with HLA-LOH Assay
-
Duarte, California
- +6 more
Feb 10, 2023
Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in United States (GRT-C903, GRT-R904, nivolumab)
Recruiting
- Non-Small Cell Lung Cancer
- +4 more
- GRT-C903
- +3 more
-
Phoenix, Arizona
- +13 more
Jan 30, 2023
Colorectal Cancer, Metastatic Colorectal Cancer Trial in United States (Onvansertib, FOLFIRI, Bevacizumab)
Recruiting
- Colorectal Cancer
- Metastatic Colorectal Cancer
- Onvansertib
- +2 more
-
Birmingham, Alabama
- +38 more
Jan 25, 2023
Colorectal Cancer Trial in Rochester (Text Messaging)
Active, not recruiting
- Colorectal Cancer
- Text Messaging
-
Rochester, New YorkStrong Hospital
Jan 11, 2023
An Optimized Multi-Target Stool DNA Test, for Colorectal Cancer
Active, not recruiting
- Colorectal Cancer
- mt-sDNA 2.0 screening test
- +2 more
-
Birmingham, Alabama
- +191 more
Jan 9, 2023
2019-01: "Clinical Validation ofOptimized Multi-Target Stool DNA
Active, not recruiting
- Colorectal Cancer
- Blood Sample Collection
-
Birmingham, Alabama
- +189 more
Jan 9, 2023
Validation for Early Cancer Detection and Minimal Residual
Recruiting
- Brain Cancer
- +19 more
-
Duarte, California
- +6 more
Nov 10, 2022
Breast Cancer, Colorectal Cancer, Ovarian Cancer Trial in United States (ATRC-101, Pembrolizumab, Pegylated liposomal
Recruiting
- Breast Cancer
- +15 more
- ATRC-101
- +2 more
-
Phoenix, Arizona
- +10 more
Sep 28, 2022
Patient Outcomes After Hepatic Artery Infusion Pump Placement
Recruiting
- Colorectal Liver Metastases
- Colorectal Cancer
-
Rochester, MinnesotaMayo Clinic Rochester
Jul 18, 2022
Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial in Worldwide (Nivolumab, Trametinib, Ipilimumab)
Recruiting
- Colorectal Cancer
- +3 more
- Nivolumab
- +3 more
-
Birmingham, Alabama
- +101 more
Jun 13, 2022
Colorectal Cancer Trial in Worldwide (Napabucasin, Fluorouracil, Leucovorin)
Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY314, Combination Therapy: PY314 +
Recruiting
- Advanced Solid Tumor
- +8 more
- PY314
- Combination Therapy: PY314 + Pembrolizumab
-
Scottsdale, Arizona
- +12 more
Mar 28, 2022
NSCLC, Small Cell Lung Cancer, Urothelial Carcinoma Trial in United States (N-803 + Pembrolizumab, N-803 + Nivolumab, N-803 +
Active, not recruiting
- Non-Small Cell Lung Cancer
- +12 more
- N-803 + Pembrolizumab
- +9 more
-
Anchorage, Alaska
- +34 more
Apr 4, 2022
Colorectal Cancer Trial in Canada, Puerto Rico, United States (celecoxib, 5-fluorouracil, )
Colorectal Cancer Trial in Worldwide (Nivolumab, Oxaliplatin, Leucovorin)
Active, not recruiting
- Colorectal Cancer
- Nivolumab
- +4 more
-
Birmingham, Alabama
- +48 more
Mar 2, 2022
Colorectal Cancer Trial in Worldwide (drug, other, procedure)
Active, not recruiting
- Colorectal Cancer
- FOLFOX (chemotherapy)
- +3 more
-
Birmingham, Alabama
- +1072 more
Oct 15, 2021
Non Small Cell Lung Cancer, Colorectal Cancer, Gastroesophageal Adenocarcinoma Trial in Australia, United States (GRT-C901,
Active, not recruiting
- Non Small Cell Lung Cancer
- +3 more
- GRT-C901
- +3 more
-
Phoenix, Arizona
- +10 more
Aug 31, 2021
Multi-target Stool DNA Test, Cologuard, for CRC Screening in
Completed
- Colorectal Cancer
- mt-sDNA screening test
- Colonoscopy
-
Phoenix, Arizona
- +38 more
Jun 3, 2021
Colorectal Cancer, Carcinoma, Neuroendocrine, Tumor Metastasis Trial in United States (Yttrium 90 glass microspheres)
Completed
- Colorectal Cancer
- +2 more
- Yttrium 90 glass microspheres
-
Chicago, Illinois
- +4 more
Apr 19, 2021